Form 4 for CDNA CareDx, Inc.
Accepted 2022-10-04 00:00:00 ET · period of report 2022-10-04 · accession 0001217234-22-000174 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-10-04 | 2022-10-04 | CDNA | Valantine Hannah | Dir | A - Grant | $0.00 | +422 | 7,371 | +6% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-10-04 | A | A | 422 | $0.00 | 7,371 | D | — | — | (F1) Represents an automatic quarterly grant of common stock to the reporting person in lieu of cash for non-employee director compensation pursuant to the issuer's Outside Director Compensation Policy. |